Elsevier

Life Sciences

Volume 58, Issue 25, 17 May 1996, Pages 2355-2365
Life Sciences

Formation of adducts between 13-oxooctadecadienoic acid (13-OXO) and protein- derived thiols, in vivo and in vitro

https://doi.org/10.1016/0024-3205(96)00236-6Get rights and content

Abstract

Linoleic acid is metabolized by numerous tissues to oxidized derivatives possessing biological activity. In the current experiments, we have investigated the reaction of 13-oxooctadecadienoic acid (13-OXO) and the metabolic precursor 13-hydroxyoctadecadienoic acid (13-HODE) with cellular macromolecules and model cellular nucleophiles. Colonie mucosal expiants from Sprague-Dawley rats were incubated in the presence of [1−14C]-13-OXO or [1-14C]-13-HODE. The binding of radiolabel to the protein and nucleic acid fractions was analyzed by isopycnic centrifugation in CS2SO4. Cellular homogenates incubated with either 13-OXO or 13-HODE resulted in the binding of radiolabel to cellular protein. No significant amounts of reaction with cellular RNA or DNA were observed. To assess possible modes of reaction with cellular constituents, the oxidized fatty acids were incubated in vitro with oxygen, sulfur, or nitrogen nucleophiles including, serine, cysteine, glutathione, methionine, lysine, adenosine, and guanosine. Under physiologic conditions, in the absence of cellular homogenates, only 13-OXO was reactive. In addition, only the sulfur-containing compounds cysteine and glutathione showed significant rates of reaction. Furthermore, treatment of colonic homogenates with N-ethylmaleimide reduced the binding of [1−14C]-13-OXO to cellular protein. These data support the suggestion that 13-HODE requires metabolic activation, by dehydrogenation to 13-OXO, prior to binding to cellular protein and that protein-derived thiol groups are involved in the binding reactions.

References (27)

  • P.A.J. Henricks et al.

    Prost.

    (1991)
  • Y. Cho et al.

    Biochem. Biophys. Res. Comm.

    (1994)
  • W.C. Glasgow et al.

    Arch. Bioch. Biophys.

    (1994)
  • W.C. Glasgow et al.

    J. Biol. Chem.

    (1992)
  • A.N. Baer et al.

    J. Lipid Res.

    (1990)
  • S.M. Earles et al.

    Biochim. Biophys. Acta

    (1991)
  • M.C. Macleod et al.

    Anal. Biochem.

    (1979)
  • M.M. Bradford

    Anal. Biochem.

    (1976)
  • A.E. Brodie et al.

    Arch. Biochem. Biophys.

    (1990)
  • A.W. Bull et al.

    Prost.

    (1991)
  • J.C. Bronstein et al.

    Prost.

    (1993)
  • M.R. Buchanan et al.

    Blood

    (1993)
  • A.W. Bull et al.

    Cancer Res.

    (1984)
  • Cited by (12)

    • Quantification of bovine oxylipids during intramammary Streptococcus uberis infection

      2015, Prostaglandins and Other Lipid Mediators
      Citation Excerpt :

      Exposure to HPODE, especially 13-HPODE, induced apoptosis in T cells and endothelial cells suggesting 13-HPODE is particularly detrimental to cell survival and tissue health [46,47]. Linoleic acid-derived HODE isomers, 9- and 13-, can further be metabolized by NAD+ dehydrogenation to 9- and 13-oxoODE resulting in potent anti-inflammatory oxylipids [48,49]. In epithelial cells and macrophages, the oxoODEs robustly activate PPARγ, which contributes to limiting pro-inflammatory responses by reducing the expression of pro-inflammatory cytokines [19,49].

    • 15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids

      2015, Journal of Biological Chemistry
      Citation Excerpt :

      However, the dehydrogenase(s) responsible for the oxidation of the hydroxyl group to a carbonyl has not been identified for many of these metabolites. 5-Hydroxyeicosatetraenoic acid (5-HETE) is oxidized by 5-hydroxyeicosanoid dehydrogenase (8, 9), and there is some evidence of a 13-hydroxyoctadecadienoic acid (13-HODE) dehydrogenase that converts 13-HODE and 9-HODE to their corresponding oxo-octadecadienoic acid metabolites (10). Notably, all of the 15PGDH substrates thus described are metabolites of arachidonic acid, with the exception of (5(S),12(R),18(R))-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid (resolvin E1) (11).

    • Glutathione adducts of oxyeicosanoids

      2002, Prostaglandins and Other Lipid Mediators
    • Pyridoxamine, an inhibitor of advanced glycation reactions, inhibits advanced lipoxidation reactions: Mechanism of action of pyridoxamine

      2000, Journal of Biological Chemistry
      Citation Excerpt :

      In support of this mechanism, KODEs have been identified as products of both non-enzymatic (27, 28) and enzymatic (29, 30) peroxidation of LA and have also been detected by chemical methods in atherosclerotic plaque (31). Thiol compounds are known to react directly with KODEs, whereas their reaction with hydroperoxyoctadecadienoic acids requires autoxidizing conditions (Fe3+ and O2) (16, 17). PM also fails to react with lipid peroxides (prepared from LA using soybean lipoxygenase) under anti-oxidative conditions (anaerobic incubation in the presence of DTPA; data not shown.).

    View all citing articles on Scopus
    View full text